Vet Optimist Podcast: Interview with CEO Christina K. Lopes and Jennifer Evans
We are excited to share an inspiring and insightful episode of “The Veterinary Optimist” podcast, featuring our very own Christina Lopes, CEO and Co-Founder of The One Health Company. In this special episode, Christina opens up about her journey, from her father’s battle with cancer to the loss of several beloved family dogs, and how […]
How Does FidoCure Work?
FidoCure is pioneering a revolutionary approach to treating canine cancer – bringing the power of precision medicine from human oncology to veterinary care. As the first and only service of its kind, FidoCure provides genomic testing to identify the unique genetic markers driving each dog’s cancer. This information can guide individualized treatment plans and leverage […]
Oral Squamous Cell Carcinoma in Dogs
Squamous cell carcinoma (SCC) is the second most common oral tumor in dogs, arising from the lining of the gums and mouth. Treatment typically involves a multimodal approach, combining local therapies like surgery and radiation with systemic chemotherapy. However, traditional chemotherapy has limited efficacy, especially for tumors with higher metastatic potential like those in the […]
FidoCure Secures Patent for AI-Driven Precision Medicine
FidoCure to Transform the Precision Medicine Landscape with New Patent, Accelerating Drug Development for Dogs with Cancer
What to Know About Nasal Adenocarcinoma
Nasal adenocarcinomas are relatively uncommon but represent nearly two-thirds of nasal tumors in dogs, which are locally invasive and have a higher risk of metastasis in later stages. Radiation therapy is the primary treatment to slow tumor growth, with patients living around one year on average. Newer approaches like metronomic chemotherapy and precision medicines targeting […]
Canine Transitional Cell Carcinoma: Treatment Options and Prognosis
Transitional cell carcinoma (TCC) is the most common tumor affecting canine urinary bladders. It is highly invasive, can obstruct urinary outflow, and has a moderate metastasis rate in areas like lymph nodes and lungs. Several factors increase TCC risk, including older flea products, lawn chemicals, obesity, being female, and certain breeds like Scottish Terriers and […]
Celebrating 5 Years of Research at AACR
FidoCure by the One Health Company and Stanford University Research Shared at AACR 2024
Interview with Renowned Oncologist and Former FDA Leader Amy Abernethy
Top Downloaded Cancer Paper in 2023
Our study in Nature’s Scientific Reports was the 17th most downloaded cancer paper in 2023!
Adrenocortical Carcinoma Case Study: Pixelle
History and Initial Treatment Pixelle, a 13 year old Shih Tzu, started her long cancer journey in June of 2020 when she was diagnosed with a left-sided adrenal mass after undergoing a thorough workup for vomiting, polyuria/polydipsia, and intermittent urinary incontinence. A pheochromocytoma was ruled out as a low-dose dexamethasone suppression test was consistent with […]